Lipoprotein (a), D-Dimer and apolipoprotein A1 as markers of presence and severity of coronary disese;Lipoproteína (a), dímero-D y apolipoproteína A-1 como indicadores de la presencia y gravedad de la enfermedad coronaria

Medicina Clinica

Volumn 132, Issue 18, 2009, Pages 689-694

  Vacas, Marta ^b   Sagastagoitia, José Domingo ^a   Saez, Yolanda ^b   Sáez De Lafuente, Jesús Pablo ^c   Santos, Mónica ^b   Lafita, Manuel ^b   Molinero, Enrique ^a   Iriarte, José Antonio ^b  

^a HOSPITAL DE BASURTO   (Spain)

^b Fundacion para la Investigacion Y Docencia de Las Enfermedades Cardiovasculares (FIDEC)   (Spain)

^c UNIVERSITY OF THE BASQUE COUNTRY UPV EHU   (Spain)

Author keywords

Coronary disease; Haemostatic; Inflammation; Lipids

Indexed keywords

APOLIPOPROTEIN A1; APOLIPOPROTEIN B100; C REACTIVE PROTEIN; D DIMER; HIGH DENSITY LIPOPROTEIN CHOLESTEROL; LIPOPROTEIN A; LOW DENSITY LIPOPROTEIN CHOLESTEROL; TRIACYLGLYCEROL;

AGED; ARTICLE; CARDIOVASCULAR RISK; CHOLESTEROL BLOOD LEVEL; CONTROLLED STUDY; CORONARY ARTERY DISEASE; CORONARY ARTERY OBSTRUCTION; DIABETES MELLITUS; DISEASE SEVERITY; FEMALE; HUMAN; HYPERTENSION; LEUKOCYTE COUNT; MAJOR CLINICAL STUDY; MALE;

AGED; APOLIPOPROTEIN A-I; BIOLOGICAL MARKERS; CORONARY DISEASE; FEMALE; FIBRIN FIBRINOGEN DEGRADATION PRODUCTS; HUMANS; LIPOPROTEIN(A); MALE; MIDDLE AGED; SEVERITY OF ILLNESS INDEX;

EID: 67349267406     PISSN: 00257753     EISSN: 15788989     Source Type: Journal    
DOI: 10.1016/j.medcli.2008.11.037     Document Type: Article

References (29)

1. S. Oporil, and A. Oberman Non traditional cardiovascular risk factors Am J Med Sci 317 1999 193 207 (Pubitemid 30389705)
2. K. Kuulasmaa, H. Tunstall-Pedoe, A. Dobson, S. Fortmann, S. Sans, H. Tolonen for the WHO MONICA Project Estimation of contribution of changes in classic risk factors to trends in coronary event rates across the WHO MONICA project populations Lancet 355 2000 675 687 (Pubitemid 30107623)
3. E.J. Schaefer, S. Lamon-Fava, J.L. Jenner, M.Y. McNamara, J.M. Ordovas, and C.E. Davis Lipoprotein (a) levels and risk of coronary heart disease in men JAMA 271 1994 999 1003
4. A. Batalla Celorio, J.J. Rodríguez Reguero, G. Iglesias Cubero, S. Hevia Nava, S. Braga Fernández, and E. Fernández Bustillo La lipoproteína (a) es predictora de gravedad angiográfica en varones menores de 50 años con inicio clínico de enfermedad coronaria Rev Esp Cardiol 53 2000 1047 1051
5. A.R. Folsom Fibrinogen and cardiovascular risk markers Blood Coagul Fibrinolysis 10 Suppl 1 1999 S13 S16
6. J. Danesh, P. Whincup, M. Walker, L. Lennon, A. Thomson, and P. Appelby Fibrin D-Dimer and coronary heart disease: Prospective study and metaanalysis Circulation 103 2001 2323 2327 (Pubitemid 32448793)
7. M. Woodward, G.D.O. Lowe, A. Rumley, and H. Tunstall-Pedoe Fibrinogen as a risk factor for coronary heart disease and mortality in middle-age men and women. The Scottish Health Study Eur Heart J 19 1998 55 62 (Pubitemid 28112300)
8. M. Cushman, R.N. Lemaitre, L.H. Kuller, R.M. Psaty, E.M. Macy, and A.R. Sharret Fibrinolytic activation markers predict myocardial infarction in the elderly. The Cardiovascular Health Study Arterioscler Thromb Vasc Biol 19 1999 493 498 (Pubitemid 29135146)
9. R. Ross The pathogenesis of atherosclerosis: A perspective from the 1990s Nature 362 1993 801 809
10. A.C. Van der Wal, A.E. Becker, C.M. Van der Loos, and P.K. Das Site of intimal rupture or erosion of thrombosed coronary atherosclerotic plaques is characterized by an inflammatory process irrespective of the dominant plaque morphology Circulation 89 1994 36 44 (Pubitemid 24026469)
11. I. Iyigun, and Y. Bakirei Plasma concentrations of C-reactive protein and fibrinogen in ischaemic stroke J Int Med Res 30 2002 591 596 (Pubitemid 36032740)
12. L. Lind Circulating markers of inflammation and atherosclerosis Atherosclerosis 169 2003 203 214 (Pubitemid 37297466)
13. J. Danesh, P. Whincup, M. Walker, L. Lennon, A. Thomson, and P. Appleby Low grade inflammation and coronary heart disease; prospective study and updated meta-analyses BMJ 321 2000 199 204 (Pubitemid 30459555)
14. G.K. Hansson Inflammation, atherosclerosis, and coronary artery disease N Engl J Med 352 2005 1685 1695
15. J.A. Hearn, S.J. DeMaio, G.S. Roubin, M. Hammarstrom, and D. Sgoutas Predictive value of lipoprotein (a) and other serum lipoproteins in the angiographic diagnosis of coronary artery disease Am J Cardiol 66 1990 1176 1180
16. L.M. Lima, M.G. Carvalho, A.A. Loures-Vale, A.P. Fernandes, A.P. Mota, and C.P. Neto Increased serum levels of lipoprotein (a) correlated with the severity of coronary artery disease in patients submitted to angiography Arq Bras Cardiol 87 2006 225 231
17. M. Peltier, M.C. Iannetta Peltier, M.E. Sarano, J.P. Lesbre, J.L. Colas, and C.M. Tribouilloy Elevated serum lipoprotein (a) levels in an independent marker of severity of thoracic aortic atherosclerosis CHEST 121 2002 1589 1594 (Pubitemid 34499675)
18. G.H. Dahlen, J.R. Guyton, M. Attar, J.A. Farmer, J.A. Kautz, and A.M. Gotto Jr Association of levels of lipoprotein (a), plasma lipid and other lipoproteins with coronary artery disease documented by angiography Circulation 74 1986 758 765 (Pubitemid 16007192)
19. M. Horimoto, A. Hasegawa, T. Ozaki, T. Takenaka, K. Igarashi, and H. Inoue Independent predictors of severity of angiographic coronary atherosclerosis: The lack of association between impaired glucose tolerance and stenosis severity Atherosclerosis 182 2005 113 119 (Pubitemid 41188376)
20. C. Tribouilloy, M. Peltier, M. Andrejak, J.L. Rey, and J.P. Lesbre Correlation of thoracic aortic atherosclerotic plaque detected by transesophageal echocardiography and cardiovascular risk factors Am J Cardiol 82 1998 1552 1555 (Pubitemid 29006488)
21. M. Madjid, I. Awan, J.T. Willerson, and W. Casscells Leukocyte count and coronary heart disease JACC 44 2004 1945 1956
22. N. Rifai, R. Joubran, H. Yu, M. Asmi, and M. Jouma Inflammatory markers in men with angiographically documented coronary heart disease Clin Chem 45 1999 1967 1973 (Pubitemid 29522005)
23. G. Luc, J.M. Bard, J. Ferrires, A. Evans, P. Amouyel, and D. Arveiler Value of HDL cholesterol, apolipoprotein A-I, lipoprotein A-I and lipoprotein A-I/A-II in prediction of coronary heart disease. The PRIME Study Arterioscler Thromb Vasc Biol 22 2002 1155 1161 (Pubitemid 34764867)
24. S.E. Nissen, T. Tsunoda, E.M. Tuzcu, P. Schoenhagen, C.J. Cooper, and M. Yasin Effect of recombinant Apo A-1 Milano on coronary atherosclerosis in patients with acute coronary syndromes: a randomised controlled trial JAMA 290 2003 2292 2300 (Pubitemid 37430562)
25. K. Berg A new serum system in man: The Lp system Acta Pathol Microbiol Scand 59 1963 369 382
26. G. Utermann, and W. Weber Protein composition of Lp(a) lipoprotein from human plasma FEBS Lett 154 1983 357 361
27. L.A. Miles, G.M. Fless, E.G. Levin, A.M. Scanu, and E.F. Plow A potential basis for the thrombotic risks associated with lipoprotein (a) Nature 339 1989 301 303 (Pubitemid 19130695)
28. A. Smith, C. Patterson, J. Yarnell, A. Rumley, Y. Ben-Shlomo, and G. Lowe Which hemostatic markers add to the predictive value of conventional risk factors for coronary heart disease and ischemic stroke? The Caerphilly Study Circulation 112 2005 3080 3087 (Pubitemid 43113439)
29. H. Itakura, B.E. Sobel, D. Boothroyd, L.L. Leung, C. Iribarren, and A.S. Go Atherosclerotic Disease, Vascular Function and Genetic Epidemiology Advance (ADVANCE) Study. Do plasma biomarkers of coagulation and fibrinolysis differ between patients who have experienced an acute myocardial infarction versus stable exertional angina? Am Heart J 154 2007 1059 1064